To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia

NCT05140863 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia

Interventions

DRUG: HSK16149 20mg BID
DRUG: HSK16149 40mg BID
DRUG: Placebo BID

Sponsor

Haisco Pharmaceutical Group Co., Ltd.